Clinical Trial: A Study of HDM1002 Tablets on Cardiac Repolarization in Healthy Subjects

U.S., May 20 -- ClinicalTrials.gov registry received information related to the study (NCT07594847) titled 'A Study of HDM1002 Tablets on Cardiac Repolarization in Healthy Subjects' on May 06.

Brief Summary: The aim of this trial is to evaluate the effect of a single oral dose of HDM1002 tablets on the QT/QTc interval in healthy subjects.

Study Start Date: March 07

Study Type: INTERVENTIONAL

Condition: Healthy Adult Subject

Intervention: DRUG: HDM1002 200 mg

HDM1002 tablet, oral, 200 mg single dose

DRUG: HDM1002 400 mg

HDM1002 tablet, oral, 400 mg single dose

DRUG: Placebo

Placebo tablet, oral, single dose

DRUG: Moxifloxacin 400 mg

Moxifloxacin tablet, oral, 400 mg single dose

Recruitment Status: RECRUITING

Sponsor: Hangzhou...